These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1119 related items for PubMed ID: 32323781

  • 1. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY, Zhao ZQ, Bai R, Zhao W, Wang YX, Xue HQ, Sun L, Sun C, Feng W, Guo SB.
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
    Meng CY, Zhao ZQ, Bai R, Zhao W, Wang YX, Sun L, Sun C, Feng W, Guo SB.
    Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L, Zhou Z, Gan Y, Li P, Xu Y, Zhang Z, Luo F, Xu J, Zhou Q, Dai F.
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway.
    Zhang H, Jiang H, Zhang H, Liu J, Hu X, Chen L.
    Eur J Pharmacol; 2019 Sep 05; 858():172477. PubMed ID: 31228450
    [Abstract] [Full Text] [Related]

  • 8. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Sun H, Yin M, Qian W, Yin H.
    Med Sci Monit; 2018 Sep 05; 24():6178-6186. PubMed ID: 30182951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J, Bai X, Feng X, Ni J, Beretov J, Graham P, Li Y.
    BMC Cancer; 2019 Jun 24; 19(1):618. PubMed ID: 31234823
    [Abstract] [Full Text] [Related]

  • 12. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Yu XS, Du J, Fan YJ, Liu FJ, Cao LL, Liang N, Xu DG, Zhang JD.
    Oncotarget; 2016 Nov 22; 7(47):76827-76839. PubMed ID: 27765907
    [Abstract] [Full Text] [Related]

  • 13. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells.
    Hu JL, Hu XL, Guo AY, Wang CJ, Wen YY, Cang SD.
    Oncotarget; 2017 Jul 25; 8(30):49380-49394. PubMed ID: 28537902
    [Abstract] [Full Text] [Related]

  • 14. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
    Sun ZY, Jian YK, Zhu HY, Li B.
    Pathol Res Pract; 2019 Mar 25; 215(3):555-563. PubMed ID: 30661902
    [Abstract] [Full Text] [Related]

  • 15. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J, Zou Y, Jiang D.
    Int J Mol Med; 2018 Apr 25; 41(4):1845-1854. PubMed ID: 29393336
    [Abstract] [Full Text] [Related]

  • 16. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J, Liu C, Shi J, Wen K, Wang X.
    Mol Med Rep; 2022 Feb 25; 25(2):. PubMed ID: 34913077
    [Abstract] [Full Text] [Related]

  • 17. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.
    Wei Z, Xia K, Zheng D, Gong C, Guo W.
    Mol Med; 2023 Oct 03; 29(1):133. PubMed ID: 37789274
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
    Liu B, Xu L, Dai EN, Tian JX, Li JM.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30442873
    [Abstract] [Full Text] [Related]

  • 19. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G, Deng S, Guo W, Yu L, Yang J, Zhou S, Gao T.
    Mol Carcinog; 2019 Jan 21; 58(1):3-18. PubMed ID: 29964327
    [Abstract] [Full Text] [Related]

  • 20. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W, Guo H, Niu M, Zheng X, Zhang Y, Xue X, Bo Y, Guan X, Li Z, Guo Y, He L, Zhang Y, Li L, Cao J, Wu Y.
    Mol Cancer; 2020 Nov 24; 19(1):166. PubMed ID: 33234130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.